Werner Sean's Form 4 filing
Biolife Solutions Inc (BLFS) · filed Mar 5, 2025
- Accession no.
- 0001628280-25-010568
- Filed
- Mar 5, 2025
- Trade date
- Mar 3-4, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $5.58K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Werner SeanCIK 0002047541 | Officer (Chief Technology Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | Common Stock | SSaleDisposed | −136 | $25.46 | −$3,462.56 | 4,953 | Direct | |
| Mar 4, 2025 | Common Stock | SSaleDisposed | −88 | $24.03 | −$2,114.64 | 4,865 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.